Valeo Financial Advisors, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 189 filers reported holding REPLIGEN CORP in Q1 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2021$17,0000.0%86
-3.4%
0.00%0.0%
Q4 2020$17,000
+21.4%
89
-5.3%
0.00%0.0%
Q3 2020$14,000
+16.7%
940.0%0.00%0.0%
Q2 2020$12,000
+33.3%
94
+5.6%
0.00%0.0%
Q1 2020$9,0000.0%89
-3.3%
0.00%0.0%
Q4 2019$9,000
+28.6%
92
-54.0%
0.00%0.0%
Q4 2017$7,000
-12.5%
2000.0%0.00%
-50.0%
Q3 2017$8,0002000.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2018
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders